Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


4 Cephalalgia

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. HASSLER SN, Ahmad FB, Burgos-Vega CC, Boitano S, et al
    Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice.
    Cephalalgia. 2018 Jan 1:333102418779548. doi: 10.1177/0333102418779548.
    PubMed     Text format     Abstract available

  2. BURGOS-VEGA CC, Quigley LD, Trevisan Dos Santos G, Yan F, et al
    Non-invasive dural stimulation in mice: A novel preclinical model of migraine.
    Cephalalgia. 2018 Jan 1:333102418779557. doi: 10.1177/0333102418779557.
    PubMed     Text format     Abstract available

  3. SKLJAREVSKI V, Matharu M, Millen BA, Ossipov MH, et al
    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
    Cephalalgia. 2018 Jan 1:333102418779543. doi: 10.1177/0333102418779543.
    PubMed     Text format     Abstract available

    Subclinical hypothyroidism is associated with migraine: A case-control study; methodological and statistical issues.
    Cephalalgia. 2018 Jan 1:333102418779542. doi: 10.1177/0333102418779542.
    PubMed     Text format    


  5. DODICK DW, Silberstein SD, Bigal ME, Yeung PP, et al
    Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
    JAMA. 2018;319:1999-2008.
    PubMed     Text format     Abstract available

  6. LODER EW, Robbins MS
    Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea.
    JAMA. 2018;319:1985-1987.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.